Dsicover a recent study that compared Stockholm3 with other established biomarkers for prostate cancer screening. Learn more.

Mr Bailey said a recent prostate cancer death prompted him to get tested. Inviting the Mail as he underwent a PSA test ... and after a number of scowling faces stared at me, I went off and ...

Artificial intelligence can help urologists and oncologists make treatment recommendations that are objective and evidence-based.

He had a PSA test as a result of the publicity, was diagnosed with prostate cancer and had the operation seven weeks ago. Like me, he had no symptoms. It’s constant. It’s happened hundreds of ...

Other researchers have argued that since PSA screening for prostate cancer began, the percentage of men who die from the disease has decreased. Ablin cites several reasons for this. Most important is ...

Cancer patients invariably develop resistance to targeted drugs, so drugmakers develop strategies to combat it before ...

Dr. Bruce Montgomery, a UW Medicine oncologist, hopes that patients won't see these numbers and just throw up their hands in fear or resignation.

Prostate cancer has distinct genetic properties in different groups of men that can be targeted to improve patient outcomes, ...

Prostate cancer has distinct genetic properties in different groups of men that could be targeted to improve patient outcomes, new research suggests.

A new study provides the strongest evidence to date on the clinical utility of a polygenic score for prostate cancer ...

Nearly all men with a polygenic risk score in the 90th percentile or above had a 10-year absolute risk for prostate cancer exceeding 3.8%. A polygenic risk score (PRS) identifies more patients with ...